semaglutide blindness study Nordisk slams linking rare to Semaglutide may cause blindness—US study

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response

This effect immediately suggested that chemical agonists similar to GLP-1 could be effective drugs to treat type 2 diabetes

Could GLP-1 Agonists Be Protective

Kanwal, F., Kramer, J

Aside from providing protection for the active ingredient, these patents also disclose that semaglutide can be used to treat various indications, including diabetes, obesity and cognitive disorders, as well as in combination with other drugs

For low initial population densities (bottom row), the probability of replicating remains well below the probability of dying